$5.78
0.09041.59%
Last update: Nov 10, 10:21 AM
Bioage Labs Inc
BIOANASDAQ
Bioage Labs fell 24.0% from $7.49 to $5.69, behind the S&P 500's +10.5%. Its worst day was Jul 31 (−63.6%), and its low came Oct 16 at $4.84.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
First BGE-102 MAD cohort completed in obese individuals with elevated hsCRP receiving 120 mg QD; demonstrated rapid and profound reduction in inflammatory markersBGE-102 achieved 86% reduction in hsCRP at Day 14, with
+27.2%, the year's best day · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
EPS of $-0.72 beat the $-0.73 estimate on $3.1M revenue (est. $1.9M).
−13.5% · S&P 500 −0.3%
EPS of $-0.52 beat the $-0.64 estimate on $2.8M revenue (est. $1.1M).
+1.0% · S&P 500 +0.8%
Bioage Labs closed at its highest level of the year, 235.1% above where the year started.
+3.5% · S&P 500 −0.1%
EPS of $-0.58 beat the $-0.64 estimate on $2.5M revenue (est. $1.4M).
+2.6% · S&P 500 −0.2%
Bioage Labs closed at its lowest level of the year, 35.4% below where the year started.
−9.5% · S&P 500 −1.1%
EPS of $-0.73 missed the $-0.64 estimate on $298,000.00 revenue (est. $1.4M).
−3.6% · S&P 500 +0.3%
Where it ended: a close of $5.69 on Nov 9, 2026.
Nothing in the past 12 months.
All BIOA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BIOA and SPY from Benzinga historical bars. Not investment advice.
